• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中脑脊液和血浆神经退行性变生物标志物与脑萎缩之间的关联

Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer's disease.

作者信息

Pereira Joana B, Westman Eric, Hansson Oskar

机构信息

Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.

Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.

出版信息

Neurobiol Aging. 2017 Oct;58:14-29. doi: 10.1016/j.neurobiolaging.2017.06.002. Epub 2017 Jun 17.

DOI:10.1016/j.neurobiolaging.2017.06.002
PMID:28692877
Abstract

The aggregation and deposition of amyloid-β (Aβ) peptides into plaques is an early event in Alzheimer's disease (AD), which is followed by different aspects of neurodegeneration that can be measured in the cerebrospinal fluid (CSF) or plasma using neurofilament light (NFL), neurogranin (Ng), total Tau (T-Tau), and phosphorylated tau (P-Tau) levels. The relationship between these biomarkers and regional brain atrophy across the different stages of AD remains largely unexplored. In this study, we assessed whether NFL, Ng, T-Tau, and P-Tau levels in CSF and NFL in plasma are associated with cortical thinning and subcortical volume loss in cognitively normal, mild cognitive impairment, and AD subjects with and without Aβ pathology. Our main findings showed that CSF NFL levels were associated with brain atrophy in all groups, but plasma NFL only correlated with atrophy in symptomatic cases. In contrast, Ng was associated with regional brain atrophy only in individuals with Aβ pathology. Altogether, our main findings suggest that Ng is strongly associated with Aβ pathology, whereas NFL is more unspecific.

摘要

淀粉样β(Aβ)肽聚集并沉积形成斑块是阿尔茨海默病(AD)的早期事件,随后会出现神经退行性变的不同方面,可通过使用神经丝轻链(NFL)、神经颗粒素(Ng)、总tau蛋白(T-Tau)和磷酸化tau蛋白(P-Tau)水平在脑脊液(CSF)或血浆中进行检测。这些生物标志物与AD不同阶段全脑萎缩之间的关系在很大程度上仍未得到探索。在本研究中,我们评估了脑脊液中的NFL、Ng、T-Tau和P-Tau水平以及血浆中的NFL水平是否与认知正常、轻度认知障碍以及伴有或不伴有Aβ病理改变的AD受试者的皮质变薄和皮质下体积减少相关。我们的主要研究结果表明,脑脊液NFL水平与所有组的脑萎缩相关,但血浆NFL仅与有症状病例的萎缩相关。相比之下,Ng仅与有Aβ病理改变个体的全脑萎缩相关总的来说,我们的主要研究结果表明,Ng与Aβ病理改变密切相关,而NFL的相关性则更不具有特异性。

相似文献

1
Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer's disease.阿尔茨海默病中脑脊液和血浆神经退行性变生物标志物与脑萎缩之间的关联
Neurobiol Aging. 2017 Oct;58:14-29. doi: 10.1016/j.neurobiolaging.2017.06.002. Epub 2017 Jun 17.
2
Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.阿尔茨海默病患者纵向血浆神经丝轻链与神经退行性变的关系。
JAMA Neurol. 2019 Jul 1;76(7):791-799. doi: 10.1001/jamaneurol.2019.0765.
3
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum.神经退行性变、突触完整性和星形胶质细胞激活的脑脊液生物标志物在整个临床阿尔茨海默病谱中。
Alzheimers Dement. 2019 May;15(5):644-654. doi: 10.1016/j.jalz.2019.01.004. Epub 2019 Mar 8.
4
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease.阿尔茨海默病中的脑脊液tau蛋白、神经颗粒素和神经丝轻链蛋白
EMBO Mol Med. 2016 Oct 4;8(10):1184-1196. doi: 10.15252/emmm.201606540. Print 2016 Oct.
5
Comparison of CSF neurofilament light chain, neurogranin, and tau to MRI markers.比较 CSF 神经丝轻链、神经颗粒素和 tau 与 MRI 标志物。
Alzheimers Dement. 2021 May;17(5):801-812. doi: 10.1002/alz.12239. Epub 2021 Mar 4.
6
Relationship between cerebrospinal fluid neurodegeneration biomarkers and temporal brain atrophy in cognitively healthy older adults.认知健康老年人的脑脊液神经退行性生物标志物与颞叶脑萎缩的关系。
Neurobiol Aging. 2022 Aug;116:80-91. doi: 10.1016/j.neurobiolaging.2022.04.010. Epub 2022 Apr 22.
7
Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.特发性正常压力脑积水神经退行性生物标志物的脑脊液时间趋势。
J Alzheimers Dis. 2021;80(4):1629-1642. doi: 10.3233/JAD-201361.
8
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic dysfunction, and axonal injury relate to atrophy in structural brain regions specific to Alzheimer's disease.神经退行性变、突触功能障碍和轴突损伤的脑脊液生物标志物与特定于阿尔茨海默病的大脑结构区域的萎缩有关。
Alzheimers Dement. 2020 Jun;16(6):883-895. doi: 10.1002/alz.12087. Epub 2020 May 6.
9
Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease.非β-淀粉样蛋白/tau 脑脊液标志物可提示阿尔茨海默病的分期和进展。
Alzheimers Res Ther. 2018 Sep 25;10(1):98. doi: 10.1186/s13195-018-0426-3.
10
Subtle Differences in Cognition in 70-Year-Olds with Elevated Cerebrospinal Fluid Neurofilament Light and Neurogranin: A H70 Cross-Sectional Study.70 岁老年人脑脊液神经丝轻链和神经颗粒素升高认知的细微差异:一项 H70 横断面研究。
J Alzheimers Dis. 2023;91(1):291-303. doi: 10.3233/JAD-220452.

引用本文的文献

1
CSF total tau as a proxy of synaptic degeneration.脑脊液总tau蛋白作为突触退化的替代指标。
Nat Commun. 2025 Aug 29;16(1):8076. doi: 10.1038/s41467-025-63545-5.
2
Soluble cerebral Aβ protofibrils link Aβ plaque pathology to changes in CSF Aβ/Aβ ratios, neurofilament light and tau in Alzheimer's disease model mice.可溶性脑淀粉样前体蛋白原纤维将阿尔茨海默病模型小鼠的淀粉样斑块病理与脑脊液中Aβ/Aβ比值、神经丝轻链和tau蛋白的变化联系起来。
Nat Aging. 2025 Mar;5(3):366-375. doi: 10.1038/s43587-025-00810-8. Epub 2025 Feb 12.
3
Alzheimer's disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges.
阿尔茨海默病:流行病学、风险因素、症状诊断、管理、护理、先进治疗方法及相关挑战的全面综述
Front Med (Lausanne). 2024 Dec 16;11:1474043. doi: 10.3389/fmed.2024.1474043. eCollection 2024.
4
The CSF p-tau/β-amyloid 42 ratio correlates with brain structure and fibrillary β-amyloid deposition in cognitively unimpaired individuals at the earliest stages of pre-clinical Alzheimer's disease.在临床前阿尔茨海默病的最早阶段,脑脊液中磷酸化tau蛋白与β淀粉样蛋白42的比值与认知未受损个体的脑结构和纤维状β淀粉样蛋白沉积相关。
Brain Commun. 2024 Dec 13;7(1):fcae451. doi: 10.1093/braincomms/fcae451. eCollection 2025.
5
Association between blood-based protein biomarkers and brain MRI in the Alzheimer's disease continuum: a systematic review.基于血液的蛋白生物标志物与阿尔茨海默病连续体中的脑 MRI 的关联:系统评价。
J Neurol. 2024 Nov;271(11):7120-7140. doi: 10.1007/s00415-024-12674-w. Epub 2024 Sep 12.
6
Potential Application of MicroRNAs and Some Other Molecular Biomarkers in Alzheimer's Disease.微小RNA及其他一些分子生物标志物在阿尔茨海默病中的潜在应用
Curr Issues Mol Biol. 2024 May 22;46(6):5066-5084. doi: 10.3390/cimb46060304.
7
Identification of Candidate Protein Biomarkers Associated with Domoic Acid Toxicosis in Cerebrospinal Fluid of California Sea Lions ().鉴定与加利福尼亚海狮()脑中的软骨藻酸中毒相关的候选蛋白生物标志物。
J Proteome Res. 2024 Jul 5;23(7):2419-2430. doi: 10.1021/acs.jproteome.4c00103. Epub 2024 May 28.
8
Biofluid biomarkers for Alzheimer's disease.用于阿尔茨海默病的生物流体生物标志物。
Front Aging Neurosci. 2024 Apr 10;16:1380237. doi: 10.3389/fnagi.2024.1380237. eCollection 2024.
9
Neurofilaments Light Chain in Neurodegenerative Dementias: A Review of Imaging Correlates.神经退行性痴呆中的神经丝轻链:影像学相关性综述
Brain Sci. 2024 Mar 13;14(3):272. doi: 10.3390/brainsci14030272.
10
Characterization of preclinical Alzheimer's disease model: spontaneous type 2 diabetic cynomolgus monkeys with systemic pro-inflammation, positive biomarkers and developing AD-like pathology.临床前阿尔茨海默病模型的特征:具有全身炎症反应、阳性生物标志物且发展出 AD 样病理学的自发性 2 型糖尿病食蟹猴。
Alzheimers Res Ther. 2024 Mar 8;16(1):52. doi: 10.1186/s13195-024-01416-9.